Merck, Canadian Plaintiffs Settle Vioxx Litigation For Up To $ 36.3M
Merck Sharp & Dohme Corp. and plaintiffs’ counsel in four Canadian Vioxx class actions announced Jan. 19 that they have agreed to settle the litigation for up to $ 36.3 million (Mignacca, et al. v. Merck Frosst Canada Ltd, et al., No. 04-CV-045435CP, Ontario Super. Ct. of Justice; Pelletier v. Merck & Co. Inc., et al., No. 500-06-000437-083, and Sigouin, et al. v. Merck & Co. Inc., et al., No. 500-06-000246-047, Quebec Superior Court, Montreal Dist.; Bray, et al. v. Merck Frosst Canada Ltd, et al., Q.B. No. 1727 of 2004, Court of Queen’s Bench of Saskatchewan).
View full post on LexisNexis® Mealey’s™ Daily Legal News
36.3M, Canadian, litigation, Merck, Plaintiff's, Settle, Vioxx